On November 17, Organon and its China-based partner Henlius announced that the FDA has approved the first pertuzumab biosimilar. The Perjeta biosimilar was dubbed Poherdy (pertuzumab-dpzb). Poherdy is approved for use for all of the indications of the reference product Perjeta (manufacturer, Roche). Pertuzumab is an HER2/neu-receptor agonist that is used in combination with trastuzumab … Continue reading First Pertuzumab Biosimilar Approved by the FDA: Poherdy by Henlius and Organon